These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15799211)

  • 61. Comparison of Alora estradiol matrix transdermal delivery system with oral conjugated equine estrogen therapy in relieving menopausal symptoms. Alora Study Group.
    Good WR; John VA; Ramirez M; Higgins JE
    Climacteric; 1999 Mar; 2(1):29-36. PubMed ID: 11915854
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Single dose nasal 17beta-estradiol administration reduces sympathovagal balance to the heart in postmenopausal women.
    Kaya D; Cevrioglu S; Onrat E; Fenkci IV; Yilmazer M
    J Obstet Gynaecol Res; 2003 Dec; 29(6):406-11. PubMed ID: 14641691
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A randomized comparison of continuous combined transdermal delivery of estradiol-norethindrone acetate and estradiol alone for menopause. CombiPatch Study Group.
    Archer DF; Furst K; Tipping D; Dain MP; Vandepol C
    Obstet Gynecol; 1999 Oct; 94(4):498-503. PubMed ID: 10511348
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Effectiveness and tolerance of pulsed estrogen therapy in the treatment of menopausal symptoms. Results of a Polish multicenter study].
    Szamatowicz M
    Ginekol Pol; 2005 Mar; 76(3):245-51. PubMed ID: 16018146
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A clinical trial of 3 doses of transdermal 17beta-estradiol for preventing postmenopausal bone loss: a preliminary study.
    Yang TS; Chen YJ; Liang WH; Chang CY; Tai LC; Chang SP; Ng HT
    J Chin Med Assoc; 2007 May; 70(5):200-6. PubMed ID: 17524997
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Intranasal salcatonin (salmon calcitonin). A review of its pharmacological properties and role in the management of postmenopausal osteoporosis.
    Plosker GL; McTavish D
    Drugs Aging; 1996 May; 8(5):378-400. PubMed ID: 8935399
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effects of the route of estrogen administration on insulinlike growth factor-I, IGF binding protein-3, and insulin resistance in healthy postmenopausal women: results from a randomized, controlled study.
    Davis SR; Stuckey BG; Norman RJ; Papalia MA; Drillich A; Bell RJ
    Menopause; 2008; 15(6):1065-9. PubMed ID: 18806686
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pulsed estrogen therapy: pharmacokinetics of intranasal 17-beta-estradiol (S21400) in postmenopausal women and comparison with oral and transdermal formulations.
    Devissaguet JP; Brion N; Lhote O; Deloffre P
    Eur J Drug Metab Pharmacokinet; 1999; 24(3):265-71. PubMed ID: 10716066
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Comparison of a transdermal continuous combined and an interrupted progestogen HRT.
    Cameron ST; Glasier AF; Gebbie A; Dewart H; Baird DT
    Maturitas; 2006 Jan; 53(1):19-26. PubMed ID: 16325020
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effects of intranasal estradiol treatment on serum paraoxonase and lipids in healthy, postmenopausal women.
    Fenkci IV; Serteser M; Fenkci S; Akyol AM
    Gynecol Obstet Invest; 2006; 61(4):203-7. PubMed ID: 16479138
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Intranasal continuous combined 17 beta-estradiol/norethisterone therapy improves the lipid profile in healthy postmenopausal women.
    Hemelaar M; Kenemans P; de Bie L; van de Weijer PH; van der Mooren MJ
    Fertil Steril; 2006 Apr; 85(4):979-88. PubMed ID: 16580384
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Ultralow-dose micronized 17beta-estradiol and bone density and bone metabolism in older women: a randomized controlled trial.
    Prestwood KM; Kenny AM; Kleppinger A; Kulldorff M
    JAMA; 2003 Aug; 290(8):1042-8. PubMed ID: 12941676
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effects of transdermal estradiol delivered by a matrix patch on bone density in hysterectomized, postmenopausal women: a 2-year placebo-controlled trial.
    Arrenbrecht S; Boermans AJ
    Osteoporos Int; 2002; 13(2):176-83. PubMed ID: 11908492
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Micro-dose transdermal estradiol for relief of hot flushes in postmenopausal Asian women: a randomized controlled trial.
    Haines C; Yu SL; Hiemeyer F; Schaefers M
    Climacteric; 2009 Oct; 12(5):419-26. PubMed ID: 19479489
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Basic principles of hormone replacement therapy in the postmenopause].
    Dören M
    Ther Umsch; 2000 Oct; 57(10):628-34. PubMed ID: 11081374
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
    Stephenson K; Neuenschwander PF; Kurdowska AK
    Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Safety and acceptability of intravaginal rings releasing estradiol and progesterone.
    Hull ML; Stuckey B; Hartman K; Zack N; Thurman A; Friend DR
    Climacteric; 2023 Oct; 26(5):465-471. PubMed ID: 37054722
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A randomized, double-blind, placebo-controlled study of the lowest effective dose of drospirenone with 17β-estradiol for moderate to severe vasomotor symptoms in postmenopausal women.
    Archer DF; Schmelter T; Schaefers M; Gerlinger C; Gude K
    Menopause; 2014 Mar; 21(3):227-35. PubMed ID: 23963307
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effects of low-dose hormone therapy on menopausal symptoms, bone mineral density, endometrium, and the cardiovascular system: a review of randomized clinical trials.
    Peeyananjarassri K; Baber R
    Climacteric; 2005 Mar; 8(1):13-23. PubMed ID: 15804728
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Efficacy of a new 7-day transdermal sequential estradiol/levonorgestrel patch in women.
    von Holst T; Salbach B
    Maturitas; 2002 Mar; 41(3):231-42. PubMed ID: 11886769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.